Journal: bioRxiv
Article Title: Rasal1 impairment unleashes anticancer immunity - a focus on T cells
doi: 10.64898/2026.01.19.700452
Figure Lengend Snippet: AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in females; B16F10-PDL1 one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .
Article Snippet: The cell lines derive from ATCC, except for the B16F10-PDL1 cell which was kindly donated to us by Dr Michel Ardolino of the University of Ottawa, ON, Canada[ ].
Techniques: In Vivo, Two Tailed Test